Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
Details for Australian Patent Application No. 2001266272 (hide)
International Classifications
Event Publications
6 March 2003 Change of Name(s) of Applicant(s), Section 104
MBT Munich Biotechnology AG The name of the applicant has been changed to Munich Biotech AG
7 July 2005 Assignment before Grant
Munich Biotech AG The application has been assigned to MediGene Oncology GmbH
15 September 2005 Application Accepted
Published as AU-B-2001266272
19 January 2006 Standard Patent Sealed
5 October 2006 Assignment Registered
MediGene Oncology GmbH The patent has been assigned to MediGene AG 2001272248 2679965 Canada Inc. The patent has been assigned to Vogue Pool Products Inc.
1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser